 |
|
|
|
|
|
 |
 |
 |
 |
 |
|
Elusys Therapeutics is committed to developing new biotherapeutic products that dramatically improve treatment of life-threatening infectious disease.
|
ANTHIM™
|
|
|
|
ETI-211
|
|
|
|
Heteropolymer Antibodies
|
NEWS
June 16th, 2009
Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
read more >>
Elizabeth Posillico, PhD inducted into NJ’s High Tech Hall of Fame
read more >>
April 22nd, 2008
Elusys’ Anthim™ Dramatically Improves Survival of Animals Treated...
read more >>
LEARN MORE ABOUT...
Our product pipeline
New approaches for the treatment of infectious disease
learn more >>
Working at Elusys
A dynamic, creative environment to advance your career
learn more >>